157 related articles for article (PubMed ID: 31989907)
1. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization.
Arslan M; Degirmencioglu S
Curr Med Imaging Rev; 2019; 15(4):380-385. PubMed ID: 31989907
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.
He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY
J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Upasena A; Sirigampala C; de Silva HJ
BMC Gastroenterol; 2015 Aug; 15():96. PubMed ID: 26239844
[TBL] [Abstract][Full Text] [Related]
4. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
[TBL] [Abstract][Full Text] [Related]
5. A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
Khalaf MH; Sundaram V; AbdelRazek Mohammed MA; Shah R; Khosla A; Jackson K; Desai M; Kothary N
Radiology; 2019 Jan; 290(1):254-261. PubMed ID: 30299233
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment.
Lima M; Dutra S; Gomes FV; Bilhim T; Coimbra É
Acta Med Port; 2018 Jan; 31(1):22-29. PubMed ID: 29573765
[TBL] [Abstract][Full Text] [Related]
7. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
8. Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Bai J; Huang M; Zhou J; Song B; Hua J; Ding R
Sci Rep; 2024 Feb; 14(1):3303. PubMed ID: 38332011
[TBL] [Abstract][Full Text] [Related]
9. Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer.
Blackburn H; West S
Cancer Nurs; 2016; 39(5):E1-E18. PubMed ID: 26484962
[TBL] [Abstract][Full Text] [Related]
10. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization.
Yinglu F; Changquan L; Xiaofeng Z; Bai L; Dezeng Z; Zhe C
J Altern Complement Med; 2009 Feb; 15(2):175-81. PubMed ID: 19216654
[TBL] [Abstract][Full Text] [Related]
11. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.
Roehlen N; Stoehr F; Müller L; Luxenburger H; Gairing SJ; Reincke M; Schultheiss M; Berisha F; Weinmann A; Foerster F; Marquardt JU; Thimme R; Galle PR; Bettinger D; Kloeckner R
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756031
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma.
Simasingha N; Tanasoontrarat W; Claimon T; Sethasine S
World J Gastroenterol; 2023 Feb; 29(5):890-903. PubMed ID: 36816622
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
Feng YL; Ling CQ; Li B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):534-6. PubMed ID: 16025970
[TBL] [Abstract][Full Text] [Related]
14. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial.
Pan Y; Chang R; He Z; Hong M
Medicine (Baltimore); 2021 Apr; 100(14):e25360. PubMed ID: 33832116
[TBL] [Abstract][Full Text] [Related]
15. Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead.
Pomoni M; Malagari K; Moschouris H; Spyridopoulos TN; Dourakis S; Kornezos J; Kelekis A; Thanos L; Chatziioanou A; Hatjimarkou I; Marinis A; Koskinas J; Kelekis D
Hepatogastroenterology; 2012 May; 59(115):820-5. PubMed ID: 22024228
[TBL] [Abstract][Full Text] [Related]
16. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.
Mason MC; Massarweh NN; Salami A; Sultenfuss MA; Anaya DA
HPB (Oxford); 2015 Dec; 17(12):1137-44. PubMed ID: 26374137
[TBL] [Abstract][Full Text] [Related]
17. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
Li CP; Chao Y; Chen LT; Lee RC; Lee WP; Yuan JN; Yen SH; Lee SD
Scand J Gastroenterol; 2008 Aug; 43(8):992-9. PubMed ID: 19086281
[TBL] [Abstract][Full Text] [Related]
18. Nausea and vomiting after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
Wang SY; Zhu WH; Vargulick S; Lin SB; Meng ZQ
Asian Pac J Cancer Prev; 2013; 14(10):5995-6000. PubMed ID: 24289614
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Opioid Medication Use after Conventional Chemoembolization versus Drug-Eluting Embolic Chemoembolization.
Khalaf MH; Shah RP; Green V; Vezeridis AM; Liang T; Kothary N
J Vasc Interv Radiol; 2020 Aug; 31(8):1292-1299. PubMed ID: 32654960
[TBL] [Abstract][Full Text] [Related]
20. Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer.
Bian LF; Zhao XH; Gao BL; Zhang S; Ge GM; Zhan DD; Ye TT; Zheng Y
World J Gastroenterol; 2020 Aug; 26(30):4442-4452. PubMed ID: 32874056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
